Fierce Pharma

Teva debuts Weltruza in schizophrenia as much-hyped FDA nod for long-acting olanzapine arrives

With a Friday go-ahead from the FDA, another key piece of Teva’s innovation revamp strategy has fallen into place, further ...
Fierce Pharma

FDA’s Rasonque review documents pressure RevMed as investors jitter over KRAS subgroup data

Revolution Medicines’ stock slid 6.3% Thursday after newly released FDA review documents sparked investor unease around ...
Fierce Pharma

Fierce Pharma Asia—Novartis’ $7.8B mRNA deal; Shionogi’s $2B buy; ArriVent’s phase 3 flop

Novartis bought an mRNA-coded autoimmune T-cell engager candidate for up to $7.8 billion, as Shionogi offered $2 billion to ...
Fierce Pharma

GSK commits $800M to R&D, manufacturing hub, as Pennsylvania bonds deepen

All told, GSK is plugging more than $800 million into an overhaul of its facilities in Upper Merion Township, where ...
Fierce Pharma

Quince relaunches as IRuyla, going all in on lung disease after Hail Mary merger

After a year of rocky financials and trial readouts, Quince Therapeutics is charting a new path forward and relaunching with ...